SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-005254
Filing Date
2024-01-19
Accepted
2024-01-19 16:44:48
Documents
12
Period of Report
2024-01-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm243719d1_8k.htm   iXBRL 8-K 34271
  Complete submission text file 0001104659-24-005254.txt   205923

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nnvc-20240113.xsd EX-101.SCH 3030
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nnvc-20240113_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nnvc-20240113_pre.xml EX-101.PRE 22369
6 EXTRACTED XBRL INSTANCE DOCUMENT tm243719d1_8k_htm.xml XML 3173
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

IRS No.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36081 | Film No.: 24546171
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)